Araste F, Abnous K, Hashemi M, Taghdisi SM, Ramezani M, Alibolandi M (2018) Peptide-based targeted therapeutics: focus on cancer treatment. J Control Release 292:141–162

Article  CAS  PubMed  Google Scholar 

Asar MC, Franco A, Soendergaard M (2020) Phage display selection, identification, and characterization of novel pancreatic cancer targeting peptides. Biomolecules. https://doi.org/10.3390/biom10050714

Article  PubMed  PubMed Central  Google Scholar 

Baun C, Naghavi-Behzad M, Hildebrandt MG, Gerke O, Thisgaard H (2024) Gastrin-releasing peptide receptor as a theranostic target in breast cancer: a systematic scoping review. Semin Nucl Med 54:256–269

Article  PubMed  Google Scholar 

Becker JP, Riemer AB (2022) The importance of being presented: target validation by immunopeptidomics for epitope-specific immunotherapies. Front Immunol 13:883989

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen S, Lin T, Basu R, Ritchey J, Wang S, Luo Y, Li X, Pei D, Kara LB, Cheng X (2024) Design of target specific peptide inhibitors using generative deep learning and molecular dynamics simulations. Nat Commun 15:1611

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cheng X, Li C, Hong H, Zhou Z, Wu Z (2025) Macrocyclic RGD-peptides with high selectivity for alpha(v)beta(3) integrin in cancer imaging and therapy. RSC Med Chem 16:3077–3083

Article  CAS  Google Scholar 

Cox N, Kintzing JR, Smith M, Grant GA, Cochran JR (2016) Integrin-targeting knottin peptide-drug conjugates are potent inhibitors of tumor cell proliferation. Angew Chem Int Ed Engl 55:9894–9897

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cruz-Monserrate Z, Roland CL, Deng D, Arumugam T, Moshnikova A, Andreev OA, Reshetnyak YK, Logsdon CD (2014) Targeting pancreatic ductal adenocarcinoma acidic microenvironment. Sci Rep 4:4410

Article  PubMed  PubMed Central  Google Scholar 

Dmitrieva MD, Voitova AA, Dymova MA, Richter VA, Kuligina EV (2020) Tumor-targeting peptides search strategy for the delivery of therapeutic and diagnostic molecules to tumor cells. Int J Mol Sci. https://doi.org/10.3390/ijms22010314

Article  PubMed  PubMed Central  Google Scholar 

Dokus LE, Lajko E, Randelovic I, Mezo D, Schlosser G, Kohidai L, Tovari J, Mezo G (2020) Phage display-based homing peptide-daunomycin conjugates for selective drug targeting to PANC-1 pancreatic cancer. Pharmaceutics 12:576

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ely ZA, Kulstad ZJ, Gunaydin G, Addepalli S, Verzani EK, Casarrubios M, Clauser KR, Wang X, Lippincott IE, Louvet C, Schmitt T, Kapner KS, Agus MP, Hennessey CJ, Cleary JM, Hadrup SR, Klaeger S, Su J, Jaeger AM, Wolpin BM, Raghavan S, Smith EL, Greenberg PD, Aguirre AJ, Abelin JG, Carr SA, Jacks T, Freed-Pastor WA (2025) Pancreatic cancer-restricted cryptic antigens are targets for T cell recognition. Science 388:eadk3487

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gabernet G, Gautschi D, Muller AT, Neuhaus CS, Armbrecht L, Dittrich PS, Hiss JA, Schneider G (2019) In silico design and optimization of selective membranolytic anticancer peptides. Sci Rep 9:11282

Article  PubMed  PubMed Central  Google Scholar 

Gomari MM, Arab SS, Balalaie S, Ramezanpour S, Hosseini A, Dokholyan NV, Tarighi P (2024) Rational peptide design for targeting cancer cell invasion. Proteins 92:76–95

Article  CAS  PubMed  Google Scholar 

Hoppenz P, Els-Heindl S, Beck-Sickinger AG (2020) Peptide-drug conjugates and their targets in advanced cancer therapies. Front Chem 8:571

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hou D, Zhou H, Tang Y, Liu Z, Su L, Guo J, Pathak JL, Wu L (2025) Dynamic visualization of computer-aided peptide design for cancer therapeutics. Drug Des Devel Ther 19:1043–1065

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hu CM, Tien SC, Lo YC, Huang CH, Ko YL, Wu DN, Lee JH, Wu YT, Yu HM, Lin KG, Zong-You L, Cheng WC (2025) Innovative cyclic peptide disrupts IL-17RB-MLK4 interaction for targeted pancreatic cancer therapy. Biomed Pharmacother 184:117892

Article  CAS  PubMed  Google Scholar 

Krag DN, Shukla GS, Shen GP, Pero S, Ashikaga T, Fuller S, Weaver DL, Burdette-Radoux S, Thomas C (2006) Selection of tumor-binding ligands in cancer patients with phage display libraries. Cancer Res 66:7724–7733

Article  CAS  PubMed  Google Scholar 

Lee AC, Harris JL, Khanna KK, Hong JH (2019) A comprehensive review on current advances in peptide drug development and design. Int J Mol Sci. https://doi.org/10.3390/ijms20102383

Article  PubMed  PubMed Central  Google Scholar 

Li Y, Yang KD, Duan HY, Du YN, Ye JF (2023) Phage-based peptides for pancreatic cancer diagnosis and treatment: alternative approach. Front Microbiol 14:1231503

Article  PubMed  PubMed Central  Google Scholar 

Marqus S, Pirogova E, Piva TJ (2017) Evaluation of the use of therapeutic peptides for cancer treatment. J Biomed Sci 24:21

Article  PubMed  PubMed Central  Google Scholar 

Mohseninia N, Eisazadeh R, Mirshahvalad SA, Zamani-Siahkali N, Hormann AA, Pirich C, Iagaru A, Beheshti M (2025) Diagnostic value of gastrin-releasing peptide receptor-targeted PET imaging in oncology: a systematic review. Semin Nucl Med 55:776–788

Article  PubMed  Google Scholar 

Naeem A, Noureen N, Al-Naemi SK, Al-Emadi JA, Khan MJ (2024) Computational design of anti-cancer peptides tailored to target specific tumor markers. BMC Chem 18:39

Article  CAS  PubMed  PubMed Central  Google Scholar 

Newton MS, Cabezas-Perusse Y, Tong CL, Seelig B (2020) In vitro selection of peptides and proteins-advantages of mRNA display. ACS Synth Biol 9:181–190

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nhan NTT, Yamada T, Yamada KH (2023) Peptide-based agents for cancer treatment: current applications and future directions. Int J Mol Sci. https://doi.org/10.3390/ijms241612931

Article  PubMed  PubMed Central  Google Scholar 

Pang X, Zhao Y, Chen X, Wang M, Chen X, Yuan H, Sun Y, Han J, Zhao X (2025) Preclinical evaluation and first-in-human study of [(68)Ga]Ga-alphavbeta6-2: a novel dimeric integrin alphavbeta6-targeted PET probe for pancreatic cancer imaging. Mol Pharm 22:2650–2659

Article  CAS  PubMed  Google Scholar 

Pirouzbakht M, Zanganeh S, Afgar A, Mirzaee Khalilabadi R, Farsinejad A, Mirzaei-Parsa MJ (2025) Machine learning-driven QSAR modeling combined with molecular dynamics suggests high-affinity CD33-targeting peptides for leukemia therapy. Bioorg Med Chem 129:118332

Article  CAS  PubMed  Google Scholar 

Pouraghajan K, Mahdiuni H, Ghobadi S, Khodarahmi R (2022) LRH-1 (liver receptor homolog-1) derived affinity peptide ligand to inhibit interactions between beta-catenin and LRH-1 in pancreatic cancer cells: from computational design to experimental validation. J Biomol Struct Dyn 40:3082–3097

Article  CAS  PubMed  Google Scholar 

Saw PE, Song EW (2019) Phage display screening of therapeutic peptide for cancer targeting and therapy. Protein Cell 10:787–807

Article  PubMed  PubMed Central  Google Scholar 

Tu Y, Han Z, Pan R, Zhou K, Tao J, Liu P, Han RPS, Gong S, Gu Y (2023) Novel GRPR-targeting peptide for pancreatic cancer molecular imaging in orthotopic and liver metastasis mouse models. Anal Chem 95:11429–11439

Article  CAS  PubMed